VBI Vaccines Inc VBIVQ

Healthcare Biotechnology

VBI Vaccines Inc. is a commercial-stage biopharmaceutical company. Through its approach to virus-like particles (VLPs), including an enveloped VLP (eVLP) platform technology and a proprietary mRNA-launched eVLP (MLE) platform technology, the Company develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. The Company is focused on targeting and overcoming significant infectious diseases, including hepatitis B (HBV), coronaviruses, and cytomegalovirus (CMV), as well as aggressive cancers including glioblastoma (GBM). Its product pipeline includes an approved vaccine and multiple late- and early-stage investigational programs. PreHevbrio is its approved vaccine for hepatitis B. Its Prophylactic Candidates for coronavirus disease include VBI-2901, VBI-2905, VBI-2902, and others. VBI-1501 is its Prophylactic Candidate for cytomegalovirus. VBI-2601 and VBI-1901 are the therapeutic candidates for HBV and GBM.

GREY:VBIVQ - Post by User

VBI Vaccines Inc > Were you selling @ $2?

<< Previous

Bullboard Posts

Next >>

Post by Iownyoudailyon Sep 09, 2020 2:57pm

331 Views

Post# 31527765

Were you selling @ $2?

Get in @ $3 ...avg is $6 recommended with a high of $9

Great hold potential with COVID19 not going anywhere 2020/21/22 and pressure on vaccines like never before.

DO your own due diligence but I look at this as a screaming BUY.

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland